Why the study?
Epidemiological studies evaluating the association between adult height and CVD mortality have yielded conflicting results.
Does higher adult height reduce cardiovascular mortality?
Does higher adult height reduce cardiovascular mortality?
This meta-analysis demonstrates an inverse association between adult height and the risk of cardiovascular, coronary heart disease, and stroke mortality.
Taller height associated with lower CVD mortality; leaves open causality and clinical implications.
Background . Epidemiological studies on the association between adult height and cardiovascular disease (CVD) mortality have provided conflicting findings. We examined the association between adult height and the risk of CVD mortality. Methods . We searched PubMed, Scopus, ISI Web of Knowledge, and Google Scholar for relevant studies published up to September 2021. Prospective cohort studies that reported the risk estimates for death from CVD, coronary heart disease (CHD), and stroke were included. The random‐effects model was used to calculate summary relative risks (RRs) and 95% confidence intervals (CIs) for the highest vs. lowest categories of adult height. Results . In total, 20 prospective cohort publications were included in this systematic review and 17 in the meta‐analysis. During 5 to 41 years of follow‐up, the total number of deaths from CVD was 95,197 (51,608 from CHD and 20,319 from a stroke) among 2,676,070 participants. The summary RR comparing the highest and lowest categories of height was 0.80 (95% CI: 0.74–0.87, I 2 = 59.4%, n = 15 studies) for CVD mortality, 0.82 (95% CI: 0.74–0.90, I 2 = 70.6%, n = 12) for CHD mortality, 0.73 (95% CI: 0.67–0.80, I 2 = 0%, n = 10) for stroke mortality, 0.70 (95% CI: 0.61–0.81, I 2 = 0%, n = 4) for hemorrhagic stroke mortality, and 0.88 (95% CI: 0.72–1.08, I 2 = 0%, n = 4) for ischemic stroke mortality. Conclusion . The present comprehensive meta‐analysis provides evidence for an inverse association between adult height and the risk of CVD, CHD, and stroke mortality.
No takes yet. Share an insight, caveat, or question.
Fahim et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: